Robin Smith, MD MBA

Dr. Robin L Smith

Dr. Smith is Executive Chair of the Board of Directors of NeoStem, Inc., (NASDAQ:NBS) a leader in the emerging cellular therapy industry. Additionally, she serves as Chairman of the Board of Trustees and President of the Stem for Life foundation, a non-profit entity with the goal of raising awareness about adult stem cell therapies and their therapeutic promise, as well as supporting the advancement of research of adult stem cells.

Dr. Smith has positioned NeoStem as a leader in the emerging stem cell industry, built on a successful business model that combines a proprietary therapeutic development business and a successful contract development and manufacturing organization (CDMO) which provides services to others in the regenerative medicine industry. Under her leadership, NeoStem has successfully completed six acquisitions, one divestiture and has raised over 190 million dollars for research and development, expansion of business units, and strategic transactions. NeoStem ranked number one (for the second year in a row) in the Tri-State region and number 11 nationally on Deloitte’s 2013 Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. In 2010, NeoStem was awarded the New Economy “Best Stem Cell Company” award.